Ureteroscope Market Size & Share 2025 - 2034

Ureteroscope Market Size

The global ureteroscope market size was valued at USD 1.2 billion in 2024. The market is anticipated to grow from USD 1.3 billion in 2025 to USD 2.1 billion in 2034, growing at a CAGR of 6% from 2025 to 2034. High market growth is primarily attributed to the increasing prevalence of kidney stones and urinary tract diseases along with the growing adoption of minimally invasive devices.

The healthcare landscape globally is experiencing a substantial rise in the incidence of renal calculi and various urinary tract infections. For instance, according to the National Institute of Health (NIH), in 2023, the prevalence of kidney stone disease was 10% in the global population. Dietary practices, rising obesity rates, genetic predispositions, and growing fluid intake problems in some areas are some of the factors causing this increase. Additionally, urinary tract infections (UTIs) remain a common health concern affecting millions annually. For instance, according to a 2023 report by Greater Boston Urology, in the U.S., about 10 in 25 women and 3 in 25 men will have symptoms of a UTI during their lifetime.
 

Moreover, patients and healthcare providers are increasingly favoring minimally invasive procedures due to their reduced recovery times, lower risk of complications, and shorter hospital stays. Ureteroscopy, being a minimally invasive method for diagnosing and treating urinary tract conditions, is gaining significant traction among urologists.
 

Ureteroscopes are used to examine and treat conditions within the urinary tract, specifically the ureters and kidneys. These devices are equipped with advanced imaging capabilities and flexible design features, allowing urologists to effectively diagnose and manage urological issues such as kidney stones, strictures, and tumors with enhanced patient safety and convenience.
 

Ureteroscope Market Trends

Ureteroscopy has become important in the diagnosis and treatment of urinary tract diseases, particularly kidney stones. The advancements in ureteroscopy technologies not only enhance procedural efficacy but also significantly improve patient outcomes.
 

• High-definition (HD) and even 4K imaging technologies are used in modern ureteroscopes. These improvements enable more accurate evaluations of urinary tract disorders, better identification of stones, and improved visualization of anatomical structures.
   
• Additionally, newer ureteroscopes are also available in both flexible and rigid designs, allowing for tailored approaches depending on patient needs and the specific anatomical challenges faced during an operation.
   
• Furthermore, the development of robotic systems to aid in ureteroscopy offers improved precision and control during procedures, lowering the physical strain on surgeons and potentially producing better results. These innovations are expected to drive the overall market.
   

Ureteroscope Market Analysis

In 2021, the ureteroscope market was valued at USD 987.5 million. The following year, it saw a slight increase to USD 1 billion, and by 2023, the market further climbed to USD 1.1 billion. Based on product, the global market is segmented into flexible ureteroscope and rigid ureteroscope. The flexible ureteroscope segment accounted for the leading market share and was valued at USD 868.7 million in 2024.
 

• Flexible ureteroscopes are developed to treat problems like ureteral strictures, kidney stones, and tumors in the urinary system.
   
• Their design makes it easier to move around, which makes it less challenging for urologists to move through the complicated structure of the urinary tract.
   
• In addition, ongoing improvements in imaging technology and materials science are making these devices even better, which makes them even more popular in the market.
   

Based on usability, the ureteroscope market is segmented into reusable ureteroscopes and disposable ureteroscopes. The reusable ureteroscopes segment accounted for the leading market share and was valued at around USD 929.7 million in 2024.
 

• Reusable ureteroscopes are made to last, using high-quality materials that can handle endoscopy sterilization and can be used many times. These instruments are known for their longevity, which directly correlates to cost savings for healthcare facilities.
   
• Moreover, their design is often sophisticated, featuring advanced optics and flexible mechanisms that facilitate better navigation through the urinary tract.
   
• Thus, urologists can perform intricate procedures with enhanced precision and accuracy. This usability is particularly important in complex cases, where the anatomy may be challenging to navigate.
   

Based on application, the ureteroscope market is categorized into urolithiasis, urethral stricture, urinary tract infections, and other applications. The urolithiasis segment accounted for the leading share in the market in 2024 and is expected to reach around USD 926 million in 2034.
 

• Urolithiasis affects a substantial portion of the population across different age groups. For instance, according to Science Direct, urolithiasis is one of the most common urologic diseases worldwide, with an estimated prevalence ranging from 1% to 13% in different regions across the globe. The condition can lead to significant patient discomfort, urinary tract obstruction, and various complications if left untreated, emphasizing the need for efficient treatment options.
   
• When it comes to the management of urolithiasis, ureteroscopes are invaluable. These flexible endoscopes allow healthcare professionals to visualize and navigate the urinary tract effectively, facilitating the removal or fragmentation of stones through minimally invasive surgical techniques.

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the ureteroscope market is classified into hospitals, ambulatory surgical centers, and other end users. In 2024, the hospitals segment held the highest market share and is expected to showcase significant growth over the analysis period.
 

• Hospitals are designed to handle a wide range of medical conditions and provide a continuum of care. They often have specialized urology departments equipped with the necessary resources for surgeries and treatments, making them the primary setting for ureteroscopic procedures.
   
• Moreover, hospitals typically invest in the latest medical technologies. This includes high-definition ureteroscopes with advanced imaging capabilities and minimally invasive tools for stone removal and other procedures, creating an environment where cutting-edge treatments can be administered effectively.

The North America ureteroscope market accounted for the leading share and was valued at USD 558.2 million in 2024. Favorable reimbursement policies, coupled with a rise in awareness levels and increasing prevalence of urolithiasis, are expected to drive regional growth.
 

The U.S. market was valued at USD 451.9 million and USD 473.2 million in 2021 and 2022, respectively. The market size reached USD 526.3 million in 2024, growing from USD 497.9 million in 2023.
 

• The U.S. holds a dominant market share in the ureteroscope market, driven by a robust healthcare system and advanced technological infrastructure.
   
• The high prevalence of urological diseases, including kidney stones and other urinary tract disorders, further fuels the demand for ureteroscopic procedures.
   
• Additionally, the presence of leading medical device manufacturers and ongoing innovations in imaging technology contribute to the growth of the market in the U.S., making it a key player in the global ureteroscope landscape.
   

The Europe ureteroscope market accounted for a significant revenue share and was valued at around USD 264.4 million in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• The significant market share of Europe in the market is characterized by its well-established healthcare systems and widespread adoption of minimally invasive surgical techniques.
   
• Countries like Germany, France, and the UK are at the forefront of innovation in urological devices, benefiting from strong research and development activities.
   
• The rise in healthcare expenditures and the growing emphasis on patient-centric care also drive market growth, with European nations increasingly focusing on improving surgical outcomes through advanced ureteroscopic technologies.
   

The Germany ureteroscope market is expected to witness considerable growth over the analysis period.
 

• Germany stands out within Europe as a significant contributor to the market, largely due to its advanced healthcare infrastructure and strong focus on medical research.
   
• With a high number of urological procedures performed annually, the demand for ureteroscopes remains robust.
   
• The presence of leading medical technology companies and a high rate of adoption of new technologies further enhances Germany's market share, setting a benchmark for quality and innovation in the field of urology.
   

The Asia Pacific ureteroscope market is anticipated to grow at the highest CAGR of 8.1% during the analysis timeframe.
 

• The Asia Pacific region is experiencing rapid growth in the market, driven by increasing urbanization, changing lifestyles, and rising incidences of kidney-related ailments.
   
• Countries such as India, Japan, and China are seeing enhanced investments in healthcare infrastructure, leading to greater availability of advanced medical devices.
   
• Additionally, initiatives by governments to improve healthcare access and affordability contribute to the rising adoption of ureteroscopic procedures in the region.
   

China ureteroscope market is predicted to grow significantly over the forecast period.
 

• China is a dominant player in the market within the Asia Pacific region, owing to its vast population and increasing healthcare needs.
   
• The rising prevalence of urological diseases, coupled with ongoing healthcare reforms aimed at enhancing service delivery, has led to an uptick in ureteroscopic procedures.
   
• Furthermore, the government's push for healthcare modernization and technological advancement has fostered a conducive environment for market growth, positioning China as a key contributor to the market.
   

Brazil is experiencing significant growth in the Latin America ureteroscope market and is anticipated to record robust growth throughout the forecast period.
 

• In South America, Brazil is the leading market for ureteroscopes, propelled by an expanding healthcare system and growing public awareness regarding urological health.
   
• The country's initiatives to improve healthcare access and reduce waiting times for surgical procedures have stimulated demand for advanced surgical instruments.
   
• Additionally, Brazilian hospitals increasingly adopt minimally invasive technologies, which enhances the market for ureteroscopes and positions Brazil as a significant player in the regional landscape.
   

Saudi Arabia ureteroscope market is poised to witness substantial growth in the Middle East and Africa market during the forecast period.
 

• Saudi Arabia holds a notable position in the market within the Middle East, characterized by significant investments in healthcare infrastructure and a growing focus on advanced medical technologies.
   
• Ongoing healthcare reforms and the adoption of international standards in clinical practice are driving the demand for ureteroscopic procedures.
   
• This is further supported by increasing disposable incomes among the population, enabling more patients to seek advanced urological care.
   

Ureteroscope Market Share

Companies operating in the ureteroscope industry are actively investing in expanding their product lines while enhancing technical performance and user experience. Leading players, including Boston Scientific, Ambu, and OLYMPUS, are focusing on developing advanced ureteroscopes with improved imaging capabilities, ergonomic designs, and enhanced maneuverability. These advancements aim to simplify procedures, reduce surgery time, and ultimately improve patient outcomes. The top 5 players in the market collectively hold a share of 35%, with a focus on harnessing innovative technologies to meet the growing demand for effective endoscopic solutions.
 

Ureteroscope Market Companies

Few of the prominent players operating in the ureteroscope industry include:

• Ambu
• BD
• Boston Scientific
• Coloplast
• Dornier MedTech
• neoscope
• OLYMPUS
• OPCOM Medical
• PUSEN
• RICHARD WOLF
• STORZ
• Stryker

• Boston Scientific excels in innovative ureteroscope technology and offers a comprehensive range of products tailored for urologists. Their minimally invasive solutions enhance patient outcomes, supported by strong clinical evidence and extensive professional training.
   
• Ambu specializes in single-use ureteroscopes designed for maximum efficiency and safety, minimizing cross-contamination risks. Their lightweight, user-friendly devices facilitate quick setup and streamline surgical workflows.
   

Ureteroscope Industry News

• In July 2024, Ambu announced the U.S. Food and Drug Administration clearance of its ureteroscopy solution, consisting of the single-use digital flexible ureteroscope, aScope 5 Uretero, and the full-HD endoscopy system. This approval helped the company in enhancing its product offerings and acquiring an increased customer base.
   
• In May 2023, Boston Scientific Corporation announced U.S. Food and Drug Administration clearance of the LithoVue Elite Single-Use Digital Flexible Ureteroscope System. This development highlights the company's strategy and focuses on innovation to remain in a leading position in comparison to its peers.
   

The ureteroscope market research report includes in-depth coverage of the industry with estimates and forecasts in terms of revenue in USD Million from 2021 - 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Flexible ureteroscope
• Rigid ureteroscope

Market, By Usability

• Reusable ureteroscopes
• Disposable ureteroscopes

Market, By Application

• Urolithiasis
• Urethral stricture
• Urinary tract infections
• Other applications

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea 
• Latin America
  • Brazil
  • Mexico
  • Argentina 
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE